SOPHARMA AD - Annual meeting with investors of "Sopharma" AD

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Investor meeting 27022026.rarAnnual meeting with investors of "Sopharma" AD
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 77 / 2026

Date of issue: 2026-02-11

Short name of the issuer

SOPHARMA AD

Subject

Annual meeting with investors of "Sopharma" AD

Official market - legal basis

Art. 56. 1. 2 of Act on Public Offering

Unofficial market - legal basis

Contents of the report:

Sofia, Bulgaria, February 11, 2026 – In accordance with the requirements of Art. 100t of the the Law on Public Offering of Securities, Sopharma AD (SFA: Bulgarian Stock Exchange AD, SPH: Warsaw Stock Exchange) invites all interested parties to an investor meeting, which will be held on 27 February, 2026 at the Event Center of Sopharma Business Towers at 5 Lachezar Stanchev Str., Sofia, starting at 2:00 p.m..
During the meeting, you will be able to discuss topics related to the performance and development of the Company with representatives of the management of Sopharma AD.
To register, please fill out the attached registration form and send it to [email protected]. If you have any questions that you would like answered during the meeting, please submit them no later than 25 February, 2026 to [email protected].

Annexes

File Description

Investor meeting 27022026.rarInvestor meeting 27022026.rar Annual meeting with investors of "Sopharma" AD

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2026-02-11 Ognian Ivanov Donev Executive Director